Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMDCTSE:4483 +2.04%77 EV-to-EBITDA is 17.38 as of Aug. 29, 2026, which is 57% below its 10-year median of 40.02. GuruFocus rates TSE:4483 with a GF Score™ of 77/100 and a GF Value™ of 円5,547.38 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 517 Healthcare Providers & Services companies, JMDC ranks worse than 70.02% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, JMDC's enterprise value is 円247,421 Mil.
JMDC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円14,236 Mil. Therefore, JMDC's EV-to-EBITDA for today is 17.38.
The historical rank and industry rank for JMDC's EV-to-EBITDA or its related term are showing as below:
TSE:4483'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 14.14 Med: 40.02 Max: 97.18
Current: 17.38
During the past 10 years, the highest EV-to-EBITDA of JMDC was 97.18. The lowest was 14.14. And the median was 40.02.
TSE:4483's EV-to-EBITDA is ranked worse than 70.02% of 517
companies
in the Healthcare Providers & Services industry
Industry Median: 10.49
vs TSE:4483: 17.38
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-29), JMDC's stock price is 円3500.00.
JMDC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was 円104.950. Therefore, JMDC's PE Ratio (TTM) for today is 33.35.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
JMDC's share price for today is 円3500.00.
JMDC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円104.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for JMDC's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4483 vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, JMDC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMDC EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JMDC's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where JMDC's EV-to-EBITDA falls into.
JMDC's current Enterprise Value is 円247,421 Mil.
JMDC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14,236 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMDC (TSE:4483) has a EV-to-EBITDA of 17.38 as of Aug. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on JMDC. This is 57% below median its historical median of 40.02. Over the past decade, JMDC's EV-to-EBITDA has ranged from 14.14 to 97.18. According to the industry distribution chart, JMDC ranks #362 out of 517 companies in the Healthcare Providers & Services industry, placing it in the top 70%.
Is JMDC's EV-to-EBITDA too high?
JMDC's current EV-to-EBITDA of 17.38 is 57% below median its 10-year median of 40.02. Over the past 10 years, this metric has ranged from a low of 14.14 to a high of 97.18. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.49. JMDC's value of 17.38 is 65.7% above this industry median. Based on the distribution chart, JMDC ranks #362 out of 517 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, JMDC has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMDC's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, JMDC ranks #362 out of 517 companies for EV-to-EBITDA. This places JMDC in the lower half of its industry. The industry median EV-to-EBITDA is 10.49. JMDC's value of 17.38 is 65.7% above this benchmark. Historically, JMDC's own EV-to-EBITDA has ranged from 14.14 to 97.18 over the past decade. While the company's 10-year median is 40.02 vs. the industry median of 10.49, JMDC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.49, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMDC's current EV-to-EBITDA of 17.38 is 65.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on JMDC. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMDC's current EV-to-EBITDA is 17.38, which is 57% below median its own 10-year median of 40.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMDC stock overvalued right now?
Based on GuruFocus' analysis, JMDC (TSE:4483) is currently considered Significantly Undervalued. The stock's GF Value™ is 円5,547.38, compared to a current price of 円3,500.00 — trading 36.9% below its estimated fair value. The current EV-to-EBITDA is 17.38, which is 57% below median its 10-year median of 40.02 and 65.7% above the Healthcare Providers & Services industry median of 10.49. JMDC's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For JMDC (TSE:4483), the current EV-to-EBITDA is 17.38 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMDC (TSE:4483) Overvalued in 2026?
Based on GuruFocus' analysis, JMDC stock appears to be undervalued.
The current stock price of 円3,500.00 is trading 36.9% below its estimated GF Value™ of 円5,547.38.
GuruFocus considers JMDC to be Significantly Undervalued.
Key valuation signals for TSE:4483:
EV-to-EBITDA: 17.38 (57% below median its 10-year median of 40.02)
GF Value™: 円5,547.38 vs. price of 円3,500.00 (36.9% below fair value)
Industry Position: 65.7% above the Healthcare Providers & Services median (#362 of 517)
No single metric tells the full story. See the TSE:4483 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.
77GF Score
Get the complete analysis for TSE:4483
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4483 has been successfully added to your 
